Create a narrative

Organogenesis Holdings Community

NasdaqCM:ORGO Community

1 Narratives written by author
0 Comments on narratives written by author
9 Fair Values set on narratives written by author

Organogenesis Holdings

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

CMS Reform And Capacity Expansion Will Unlock Long Term Value

Key Takeaways Regulatory changes and clinical evidence efforts are set to boost adoption, payer coverage, and margins for premium wound care products. Facility expansion and new product launches position the company for diversified, long-term growth and improved efficiency.

US$8.00

FV

40.9% undervalued

20.62%

Revenue growth p.a.

0

0

6

Updated